Physician profile
Nabil Farakh
NPI 1699932186
$1,248.21
in general payments reported to CMS, 2019-2025
12 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $67.47 · 2021: $20.91 · 2022: $76.94 · 2023: $499 · 2024: $24.98 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $456.64 | 2020-2025 | Orthovisc, Trialtis, Na |
| Stryker Corporation | $223.85 | 2019-2023 | Mako |
| Nevro Corp. | $159.74 | 2023 | Senza |
| Smith+Nephew, INC. | $126.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $56.77 | 2022-2023 | Seglentis |
| Si-Bone, INC. | $54.18 | 2022 | |
| Orthofix Medical, INC. | $40.11 | 2025 | Cervical-Stim |
| Ebi, LLC | $38.21 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Zimmer Biomet Holdings, INC. | $24.98 | 2024 | Visco-3 Sodium Hyaluronate |
| Ferring Pharmaceuticals INC. | $23.74 | 2023 | Euflexxa |
| Fidia Pharma USA INC. | $22.97 | 2019 | |
| Abbott Laboratories | $20.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Farakh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.